Fundamental Analysis of EDENRED(EPA:EDEN) stock

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to EDEN. EDEN was compared to 15 industry peers in the Financial Services industry. While EDEN has a great profitability rating, there are some concerns on its financial health. While showing a medium growth rate, EDEN is valued expensive at the moment.

Profitability

Profitability Rating

EDEN's Return On Assets of 3.45% is amongst the best of the industry. EDEN does better than the industry average Return On Assets of 3.15%.

EDEN has a Profit Margin of 19.01%. This is amongst the best returns in the industry. The industry average is 12.82%. EDEN outperforms 81% of its industry peers.

EDEN has a very good Piotroski-F score of 9.00. This indicates a great health and profitability for EDEN.

VS Industry

ROA (3.45%) VS Industry: 63% outperformed.

0.32

14.63

Profit Margin (19.01%) VS Industry: 81% outperformed.

1.61

45.18

Valuation

Valuation Rating

EDEN's PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

With a Price/Earnings Ratio of 41.71, EDEN can be considered very expensive at the moment.

Compared to an average industry Price/Earning Ratio of 15.17, EDEN is valued more expensive than its industry peers. On top of this 82% of the companies listed in the same industry are cheaper than EDEN!

The Forward Price/Earnings Ratio of 30.22 indicates a quite expensive current valuation of EDEN.

When comparing the Enterprise Value to EBITDA ratio of EDEN to the average industry ratio of 11.98, EDEN is valued more expensive than its industry peers.

VS Industry

Price/Earnings (41.71) VS Industry: 18% outperformed.

150.76

5.84

Enterprise Value/ EBITDA (15.81) VS Industry: 30% outperformed.

58.76

1.35

Growth

Growth Rating

The Earnings Per Share has grown by an impressive 22.69% over the past year.

The Earnings Per Share is expected to grow by 19.97% on average over the next 5 years. This is quite good.

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

EDEN shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.83%.

The Earnings Per Share has been growing slightly by 6.82% on average over the past 5 years.

The Revenue has been growing slightly by 9.00% on average over the past 5 years.

Based on estimates for the next 5 years, EDEN will show a small growth in Revenue. The Revenue will grow by 6.81% on average per year.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.

	5Y	3Y	1Y	1Y	2Y	3Y	5Y
	Past			Future
EPS	6.82%	4.21%	22.69%	38.02%	26.05%	22.6%	19.97%
Revenue	9%	7.7%	24.83%	18.58%	14.98%	13.28%	6.81%

Health

Health Rating

EDEN has a very good Piotroski-F score of 9.00. This indicates a great health and profitability for EDEN.

EDEN has a Current Ratio of 0.99. This is a bad value and indicates that EDEN is not financially healthy enough and could expect problems in meeting its short term obligations.

Compared to an average industry Current Ratio of 1.68, EDEN is worse placed to pay its short term obligations than its industry peers. 100% of its industry peers have a better Current Ratio.

EDEN has a Quick Ratio of 0.99. This is a bad value and indicates that EDEN is not financially healthy enough and could expect problems in meeting its short term obligations.

When comparing the Quick Ratio of EDEN to the average industry Current Ratio of 1.57, EDEN is less able to pay its short term obligations than its industry peers. 91% of its industry peers have a better Quick Ratio.

EDEN has an Altman-Z score of 0.93. This is a bad value and indicates that EDEN is not financially healthy and even has some risk of bankruptcy.

When comparing the Altman-Z score of EDEN to the average industry Altman-Z score of 1.86, EDEN is less financially healthy than its industry peers. 82% of its industry peers have a better Altman-Z score.

VS Industry

Quick Ratio (0.99) VS Industry: 9% outperformed.

0.84

77.01

Current Ratio (0.99) VS Industry: 0% outperformed.

0.99

77.01

Altman-Z (0.93) VS Industry: 18% outperformed.

0.58

40.24

Dividend

Dividend Rating

The dividend of EDEN is nicely growing with an annual growth rate of 11.56%!

The dividend of EDEN is growing, but earnings are growing more, so the dividend growth is sustainable.

EDEN has a Yearly Dividend Yield of 1.65%. Purely for dividend investing, there may be better candidates out there.

EDEN's Dividend Yield is slightly below the industry average, which is at 3.19.

Compared to the average S&P500 Dividend Yield of 2.71, EDEN is paying slightly less dividend.

EDEN pays out 61.66% of its income as dividend. This is not a sustainable payout ratio.

VS Industry

Dividend Yield (1.65%) VS Industry: 33% outperformed.

0.56

13.48

EDENRED

EPA:EDEN (6/5/2023, 2:55:04 PM)

60.89

+0.17 (+0.28%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryFinancial Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap15.16B

Analysts80

Price Target67.25 (10.45%)

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.65%

Dividend Growth(5Y)11.56%

DP61.66%

Div Incr Years1

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)-21.18%

Min EPS beat(2)-21.18%

Max EPS beat(2)-21.18%

EPS beat(4)N/A

Avg EPS beat(4)-18.76%

Min EPS beat(4)-21.18%

Max EPS beat(4)-16.34%

Revenue beat(2)1

Avg Revenue beat(2)2.59%

Min Revenue beat(2)2.59%

Max Revenue beat(2)2.59%

Revenue beat(4)2

Avg Revenue beat(4)2.43%

Min Revenue beat(4)2.27%

Max Revenue beat(4)2.59%

PT rev (1m)3.14%

PT rev (3m)12.51%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0.65%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)6.01%

Valuation

		Industry Rank	Sector Rank
PE	41.71
Fwd PE	30.22
P/S	7.47
P/FCF	17.59
P/OCF	14.97
P/B	N/A
P/tB	N/A
EV/EBITDA	15.81

EPS(TTM)1.46

EY2.4%

EPS(NY)2.02

Fwd EY3.31%

FCF(TTM)3.46

FCFY5.69%

OCF(TTM)4.07

OCFY6.68%

SpS8.16

BVpS-2.88

TBVpS-12.29

PEG (NY)1.1

PEG (5Y)6.12

Profitability

		Industry Rank	Sector Rank
ROA	3.45%
ROE	N/A
ROIC	16.97%
ROICexc	N/A
ROICexgc	N/A
OM	33.83%
PM	19.01%
GM	91.04%

ROA(3y)3%

ROA(5y)3.2%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)15.38%

ROIC(5y)19.71%

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y0.31%

OM growth 5Y0.8%

PM growth 3Y-0.32%

PM growth 5Y0.81%

GM growth 3Y0.26%

GM growth 5Y0.47%

F-Score9

Asset Turnover0.18

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	3.53
Debt/EBITDA	3.57
Cap/Depr	92.07%
Profit Quality	223.32%
Current Ratio	0.99
Quick Ratio	0.99
Altman-Z	0.93

F-Score9

WACC7.51%

ROIC/WACCN/A

Cap/Depr(3y)87.28%

Cap/Depr(5y)92.92%

Profit Quality(3y)212.62%

Profit Quality(5y)185.43%

Growth

EPS 1Y22.69%

EPS 3Y4.21%

EPS 5Y6.82%

EPS growth Q2Q20.59%

EPS Next Y38.02%

EPS Next 2Y26.05%

EPS Next 3Y22.6%

EPS Next 5Y19.97%

Revenue growth 1Y24.83%

Revenue growth 3Y7.7%

Revenue growth 5Y9%

Revenue growth Q2Q27.47%

Revenue Next Year18.58%

Revenue Next 2Y14.98%

Revenue Next 3Y13.28%

Revenue Next 5Y6.81%

EBIT growth 1Y27.7%

EBIT growth 3Y8.02%

EBIT growth 5Y9.88%

EBIT Next Year46.8%

EBIT Next 3Y22.64%

EBIT Next 5Y21.22%

FCF growth 1Y75.92%

FCF growth 3Y32.93%

FCF growth 5Y15.69%

OCF growth 1Y67.72%

OCF growth 3Y29.63%

OCF growth 5Y15.45%

Fundamental Stock Screener Links

EDENRED (EDEN.PA)

Fundamental Rating

Profitability

Profitability Rating

VS Industry

Valuation

Valuation Rating

VS Industry

Growth

Growth Rating

Health

Health Rating

VS Industry

Dividend

Dividend Rating

VS Industry

Fundamental Stock Screener

Best Fundamental Competitors Stock Screener

Best Valuation Competitors Stock Screener

Best Dividend Competitors Stock Screener